759. Deputy Barry Heneghan asked the Minister for Health the number and name of medicines currently subject to national shortages for which pharmacies are routinely sourcing unlicensed alternatives, in tabular form; whether her Department has assessed the additional costs incurred by medical card patients as a consequence; and if she will make a statement on the matter. [52904/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
27,342 questions match, newest first.
760. Deputy Michael Cahill asked the Minister for Health to provide a list of locations where hospital sessions are available for special needs patients under general anaesthetic nationwide; the relevant waiting lists for each in each of the past four years; the number of patients treated in each unit under general anaesthetic in each of the past four years and to date in 2026; and if she will make a statement on the…
761. Deputy Michael Cahill asked the Minister for Health the waiting list numbers and waiting times for all specialist services in Dublin and Cork Dental Schools in each of the past four years and to date in 2026; and if she will make a statement on the matter. [52919/26]
762. Deputy Sorca Clarke asked the Minister for Health if she will provide details of any assessment undertaken by her Department on extending publicly funded access to the shingles vaccine for cancer patients and other immunocompromised individuals; whether such a proposal has been considered following recommendations from the National Immunisation Advisory Committee; and if she will make a statement on the matter. …
763. Deputy Sorca Clarke asked the Minister for Health the estimated annual cost of providing the shingles vaccine free-of-charge to cancer patients who are clinically advised to receive it; whether this option has been examined by her Department; and if she will publish any cost-benefit analysis undertaken. [52922/26]
764. Deputy Sorca Clarke asked the Minister for Health the number of cancer patients who have received financial assistance from the State towards the cost of the shingles vaccine in each of the past five years; and the supports currently available to patients who are advised by their consultant to receive the vaccine but cannot afford it. [52923/26]
765. Deputy Sorca Clarke asked the Minister for Health whether consideration has been given to including the shingles vaccine on the list of medicines and treatments available without charge to eligible cancer patients under publicly funded cancer care, where the vaccine is clinically indicated to reduce the risk of complications arising during treatment; and if she will make a statement on the matter. [52924/26]
766. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Questions Nos. 1085, 1086, 1089, 1092 and 1094 of 19 May 2026, which confirmed there is no separate governance structure overseeing laboratory utilisation nationally, whether her Department will now establish an interim national oversight mechanism pending full rollout of MedLIS and the Regional Laboratory Networks; and if she will make a …
767. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1089 of 19 May 2026, which confirmed MedLIS duplicate detection is currently deployed only in Beaumont Hospital and Cavan General Hospital, the projected timeline and sequencing for national rollout of MedLIS to all other hospital sites; and if she will make a statement on the matter. [52936/26]
768. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question Nos 1089 and 1092 of 19 May 2026, which referenced a Minimal Retesting Interval Guidance Document currently in development by the Laboratory Services Reform Programme, the expected publication date of this document; and if she will make a statement on the matter. [52937/26]
769. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1092 of 19 May 2026, which referenced a laboratory utilisation survey undertaken by a professional body with an offer to share findings, the name of the professional body in question; the findings shared to date; whether her Department will publish the outcome of any resulting collaboration; and if she will make a statement on…
770. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question Nos.1085 and 1086 of 19 May 2026, which confirmed no national modelling of laboratory testing costs has been undertaken and no assessment of the financial impact of duplicate or unnecessary testing has been carried out, whether her Department will now commission such an assessment given the acknowledged absence of a centralised da…
771. Deputy Cian O'Callaghan asked the Minister for Health to examine the detailed referral submitted to the HSE Safeguarding and Protection Team by a person (details supplied); the reason no substantive update has been provided following this referral; the action that is currently being taken by her Department following this referral; the reason the HSE's Mental Health Services are not currently within the remit of …
772. Deputy Pádraig Rice asked the Minister for Health the ratio of midwifes to births in each maternity hospital and unit (details supplied), in tabular form; to identify the sites classified as large units and small units under the Birthrate Plus methodology; and if she will make a statement on the matter. [52965/26]
773. Deputy Pádraig Rice asked the Minister for Health to respond to a decision in the United Kingdom to make a rapid endometriosis test (details supplied) available on the NHS in England and Wales; if there are any plans to make this test available through the HSE; if so, the steps taken to date; and if she will make a statement on the matter. [52966/26]
774. Deputy Aisling Dempsey asked the Minister for Health where falls prevention classes are currently being funded nationally. [52990/26]
775. Deputy Aisling Dempsey asked the Minister for Health if she will fund the national roll-out of falls prevention classes, given that 25% of hospital admissions from older people relate to falls. [52991/26]
776. Deputy Aisling Dempsey asked the Minister for Health if she will increase funding to an organisation (details supplied) to allow it expand daycare immediately. [52992/26]
777. Deputy Aisling Dempsey asked the Minister for Health the reason tirzepatide (Mounjaro) is authorised for the treatment of type 2 diabetes but not covered by the medical card, long-term illness scheme or drugs payment scheme. [52993/26]
778. Deputy Brendan Smith asked the Minister for Health if consideration will be given to the introduction of new tests as approved by the National Institute for Health and Care Excellence in Britain (details supplied); and if she will make a statement on the matter. [52995/26]
779. Deputy Jennifer Whitmore asked the Minister for Health the amount of State funding that has been allocated to research on adenomyosis in each of the past five years; and if she will make a statement on the matter. [53000/26]
780. Deputy Jennifer Whitmore asked the Minister for Health whether her Department has commissioned or funded any research into the prevalence, diagnosis and treatment of adenomyosis in Ireland; if she will provide details of any such research; and if she will make a statement on the matter. [53001/26]
781. Deputy Jennifer Whitmore asked the Minister for Health the measures being taken to improve data collection on adenomyosis, including the number of women diagnosed with the condition annually; and if she will make a statement on the matter. [53002/26]
782. Deputy Jennifer Whitmore asked the Minister for Health whether the HSE intends to develop clinical guidance or educational resources specifically relating to adenomyosis for primary care practitioners; and if she will make a statement on the matter. [53003/26]
783. Deputy Jennifer Whitmore asked the Minister for Health whether adenomyosis is included in the HSE's MISE (Menstrual Information Specialising in Endometriosis) Education Programme; if not, whether consideration will be given to including information on the symptoms, diagnosis and impact of adenomyosis in future MISE training materials; and if she will make a statement on the matter. [53004/26]